Taiwan FDA registration 8a8b1e15e03f4ef18eff9239fdfb4f9c
"100 first" insulin precursor C-Shengbi radioimmunoassay reagent
TW: “百首”胰島素前質C-胜呔放射免疫分析試劑
Taiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Nov 05, 2010 – Nov 05, 2025ExpiredRegistration details
- Analysis ID
- 8a8b1e15e03f4ef18eff9239fdfb4f9c
- Customs Code
- DHAS0602168109
Company information
- Manufacturer
- DIASOURCE IMMUNOASSAYS S.A.
- Manufacturer Country
- Belgium
- Authorized Representative
- TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
- Intended Use
- Radioimmunoassay reagents for the in vitro quantitative detection of C-Peptide in human serum
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1135 胰島素前質C-肽類試驗系統
- Import Information
- Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
- Registration Date
- Nov 05, 2010
- Expiry Date
- Nov 05, 2025
About this record
Access comprehensive regulatory information for "100 first" insulin precursor C-Shengbi radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8a8b1e15e03f4ef18eff9239fdfb4f9c and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices